4
Changes in Ownership
Enliven Therapeutics, Inc. Filed Acc 0001415889-24-010825
Director sold 6,964 shares at an average $24.11 ($167,888)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Heyman Richard A. · Director
Table I: Non-derivative
4 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2024-04-11 | Sale : show line 1 in the form 10b5-1 | −5,045 | $25.03 | $126,279 | 138.43 | D |
| 2024-04-15 | Sale : show line 2 in the form 10b5-1 | −1,190 | $19.94 | $23,729 | 137,235 | D |
| 2024-04-15 | Sale : show line 3 in the form 10b5-1 | −80 | $20.68 | $1,654 | 137,155 | D |
| 2024-04-11 | Sale : show line 4 in the form 10b5-1 | −649 | $25.00 | $16,225 | 28,567 | I |
| Open-market sales · 6,964 sh · avg $24.11 · $167,888 | ||||||
Loading xslF345X05/form4-04152024_110425.xml…